Switch to:
Also traded in: Germany, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.02
UHS's Cash to Debt is ranked lower than
92% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 0.33 vs. UHS: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
UHS' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.01 Max: 0.27
Current: 0.02
0
0.27
Equity to Asset 0.45
UHS's Equity to Asset is ranked higher than
50% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 0.46 vs. UHS: 0.45 )
Ranked among companies with meaningful Equity to Asset only.
UHS' s Equity to Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.42 Max: 0.49
Current: 0.45
0.26
0.49
Interest Coverage 109.14
UHS's Interest Coverage is ranked higher than
82% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 6.17 vs. UHS: 109.14 )
Ranked among companies with meaningful Interest Coverage only.
UHS' s Interest Coverage Range Over the Past 10 Years
Min: 4.47  Med: 7.44 Max: 78.52
Current: 109.14
4.47
78.52
F-Score: 8
Z-Score: 2.84
M-Score: -2.66
WACC vs ROIC
6.60%
11.62%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 13.90
UHS's Operating margin (%) is ranked higher than
72% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 7.18 vs. UHS: 13.90 )
Ranked among companies with meaningful Operating margin (%) only.
UHS' s Operating margin (%) Range Over the Past 10 Years
Min: 7.71  Med: 10.99 Max: 13.94
Current: 13.9
7.71
13.94
Net-margin (%) 7.52
UHS's Net-margin (%) is ranked higher than
65% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 4.49 vs. UHS: 7.52 )
Ranked among companies with meaningful Net-margin (%) only.
UHS' s Net-margin (%) Range Over the Past 10 Years
Min: 3.59  Med: 5.75 Max: 7.53
Current: 7.52
3.59
7.53
ROE (%) 16.88
UHS's ROE (%) is ranked higher than
72% of the 213 Companies
in the Global Medical Care industry.

( Industry Median: 9.52 vs. UHS: 16.88 )
Ranked among companies with meaningful ROE (%) only.
UHS' s ROE (%) Range Over the Past 10 Years
Min: 11.67  Med: 16.42 Max: 19.9
Current: 16.88
11.67
19.9
ROA (%) 7.48
UHS's ROA (%) is ranked higher than
70% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.79 vs. UHS: 7.48 )
Ranked among companies with meaningful ROA (%) only.
UHS' s ROA (%) Range Over the Past 10 Years
Min: 4.01  Med: 5.89 Max: 8.46
Current: 7.48
4.01
8.46
ROC (Joel Greenblatt) (%) 27.64
UHS's ROC (Joel Greenblatt) (%) is ranked higher than
64% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 17.56 vs. UHS: 27.64 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
UHS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 15.91  Med: 24.27 Max: 27.01
Current: 27.64
15.91
27.01
Revenue Growth (3Y)(%) 8.00
UHS's Revenue Growth (3Y)(%) is ranked higher than
53% of the 173 Companies
in the Global Medical Care industry.

( Industry Median: 7.40 vs. UHS: 8.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
UHS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 1.8  Med: 13.50 Max: 18.3
Current: 8
1.8
18.3
EBITDA Growth (3Y)(%) 6.60
UHS's EBITDA Growth (3Y)(%) is ranked higher than
50% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: 6.60 vs. UHS: 6.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
UHS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -3.3  Med: 14.50 Max: 29.6
Current: 6.6
-3.3
29.6
EPS Growth (3Y)(%) 14.20
UHS's EPS Growth (3Y)(%) is ranked higher than
68% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 5.90 vs. UHS: 14.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
UHS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -9.9  Med: 14.20 Max: 30
Current: 14.2
-9.9
30
» UHS's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-07-30)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

UHS Guru Trades in Q2 2015

Louis Moore Bacon 49,147 sh (New)
Andreas Halvorsen 1,220,743 sh (New)
Paul Tudor Jones 12,791 sh (+49.71%)
Lee Ainslie 1,016,491 sh (+4.80%)
Private Capital 219,664 sh (+2.41%)
Vanguard Health Care Fund 4,128,600 sh (+1.87%)
Mariko Gordon Sold Out
Jim Simons Sold Out
Larry Robbins 971,787 sh (-0.33%)
Ron Baron 409,618 sh (-0.86%)
Chris Davis 114,880 sh (-3.45%)
Westport Asset Management 724,584 sh (-3.98%)
RS Investment Management 198,786 sh (-16.46%)
Robert Olstein 41,000 sh (-33.87%)
Joel Greenblatt 105,662 sh (-53.00%)
» More
Q3 2015

UHS Guru Trades in Q3 2015

Ray Dalio 8,200 sh (New)
RS Investment Management 264,866 sh (+33.24%)
Private Capital 223,171 sh (+1.60%)
Ron Baron 409,748 sh (+0.03%)
Andreas Halvorsen Sold Out
Louis Moore Bacon Sold Out
Larry Robbins 964,895 sh (-0.71%)
Vanguard Health Care Fund 3,939,340 sh (-4.58%)
Westport Asset Management 685,391 sh (-5.41%)
Lee Ainslie 908,071 sh (-10.67%)
Chris Davis 82,120 sh (-28.52%)
Robert Olstein 20,600 sh (-49.76%)
Paul Tudor Jones 5,000 sh (-60.91%)
Joel Greenblatt 22,289 sh (-78.91%)
» More
Q4 2015

UHS Guru Trades in Q4 2015

Jeremy Grantham 15,900 sh (New)
Jim Simons 179,200 sh (New)
Steven Cohen 20,300 sh (New)
Joel Greenblatt 383,841 sh (+1622.11%)
Robert Olstein 32,000 sh (+55.34%)
Larry Robbins 1,209,602 sh (+25.36%)
Chris Davis 97,470 sh (+18.69%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
Ray Dalio Sold Out
Paul Tudor Jones Sold Out
Private Capital 219,168 sh (-1.79%)
Westport Asset Management 621,391 sh (-9.34%)
Lee Ainslie 795,832 sh (-12.36%)
RS Investment Management 224,805 sh (-15.13%)
Ron Baron 270,003 sh (-34.11%)
» More
Q1 2016

UHS Guru Trades in Q1 2016

Paul Tudor Jones 3,517 sh (New)
John Paulson 54,000 sh (New)
Andreas Halvorsen 429,887 sh (New)
Jeremy Grantham 20,700 sh (+30.19%)
Lee Ainslie 966,544 sh (+21.45%)
Jim Simons 215,000 sh (+19.98%)
Robert Olstein 34,000 sh (+6.25%)
RS Investment Management 227,613 sh (+1.25%)
Chris Davis 97,650 sh (+0.18%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
Larry Robbins Sold Out
Steven Cohen 19,800 sh (-2.46%)
Westport Asset Management 571,391 sh (-8.05%)
Ron Baron 197,664 sh (-26.79%)
Private Capital 140,550 sh (-35.87%)
Joel Greenblatt 166,650 sh (-56.58%)
» More
» Details

Insider Trades

Latest Guru Trades with UHS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:XTER:FRE, NYSE:HCA, XTER:FME, NYSE:DVA, XKLS:5225 » details
Traded in other countries:UHS.Germany, UHID.USA,
Universal Health Services Inc, through its subsidiaries is engaged in the business of owning and operating acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers.

Universal Health Services Inc is a Delaware corporation organized in 1979. The Company through its subsidiaries is engaged in the business of owning and operating, acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. The Company owned and/or operated 24 acute care hospitals and 193 behavioral health centers located in 37 states, Washington, D.C., Puerto Rico and the U.S. Virgin Islands. Services provided by hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and behavioral health services. The Company provides capital resources as well as management services to facilities, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations. The Company's reportable operating segments consist of acute care hospital services and behavioral health care services. The Other segment includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting as well as the operating results for its other operating entities including outpatient surgery and radiation centers. All of the Company's acute care hospitals and its behavioral health centers are certified as providers of Medicare and Medicaid services by the appropriate governmental authorities. Medicare is a federal program that provides certain hospital and medical insurance benefits to persons aged 65 and over, some disabled persons and persons with end-stage renal disease. Medicaid is a joint federal-state funded health care benefit program that is administered by the states to provide benefits to qualifying individuals who are unable to afford care state Medicaid payments are made under a PPS-like system, or under programs that negotiate payment levels with individual hospitals. The Company's hospitals also provide services to individuals covered by private health care insurance. Private insurance carriers typically make direct payments to hospitals or, in some cases, reimburse their policy holders, based upon the particular hospital's established charges and the particular coverage provided in the insurance policy. Its hospitals provide services to individuals that do not have any form of health care coverage. Such patients are evaluated, at the time of service or shortly thereafter, for their ability to pay based upon federal and state poverty guidelines, qualifications for Medicaid or other state assistance programs, as well as its local hospital's indigent and charity care policy. The Company faces competition for acquisition candidates mainly from other for-profit health care companies, as well as from not-for-profit entities.

Guru Investment Theses on Universal Health Services Inc

Baron Funds Comments on Universal Health Services Inc. - Aug 18, 2015

Universal Health Services, Inc. (NYSE:UHS) is a leading operator of acute care hospitals, and it is also the country’s largest provider of behavioral health services. The company’s shares rose sharply in late-June in response to the U.S. Supreme Court’s decision to uphold a key provision of the Affordable Care Act (ACA), which has expanded insurance coverage to almost 13 million Americans. The court’s decision removes meaningful future legal challenges to the ACA, which has driven a meaningful increase in hospital utilization. This court decision came on the heels of solid quarterly earnings results. As the dominant acute care provider in some of the fastest growing markets in the U.S., we continue to like Universal’s positioning and prospects. We are particularly excited about the opportunity for its behavioral health business to gain more favorable reimbursement treatment for Medicaid patients.



From Baron Funds' second quarter commentary.



Check out Ron Baron latest stock trades

Westport Select Cap Fund Comments on Universal Health Services Inc - May 29, 2015

Universal Health Services, Inc., Class B shares (UHS), the fund’s largest position, was up nearly 6%, contributing 79 basis points. The company continues to benefit from the Affordable Care Actii (“Obamacare“) as it reported strong fourth quarter results and forecast continued above average growth for 2015.

From Westport Asset Management (Trades, Portfolio)’s Westport Select Cap Fund Q1 2015 Commentary.

Check out Westport Asset Management latest stock trades

Mario Gabelli Comments on UnitedHealth Group Inc - Jul 30, 2014

UnitedHealth Group Inc. (UHS) (0.2%) (UNH - $81.75 - NYSE) is the largest and most diverse health care company in the United States. United insures over forty million people around the world, but also provides over $40 billion worth of technology, pharmacy benefits management, and other care services through its Optum division. The company has successfully navigated the changes required by the Affordable Care Act and is winning new business in state Medicaid programs and in a limited number of state exchanges. UnitedHealth is also finding new growth internationally, especially in Brazil where the company now serves over four million people.

From Mario Gabelli (Trades, Portfolio)’s The Gabelli Asset Fund Second Quarter 2014 Shareholder Commentary.

Check out Mario Gabelli latest stock trades

Westport Select Cap Fund Comments on Universal Health Services Inc - Jul 28, 2014

The second largest contributor to first half performance was Universal Health Services, Inc. (UHS), Class B shares, the fund’s largest position. The operator of acute care and mental health hospitals gained nearly 18% and contributed 182 basis points. First quarter earnings exceeded estimates, reflecting the early positive impact of the Affordable Care Act (also known as “Obamacare.”)

From Westport Asset Management (Trades, Portfolio)’s Westport Select Cap Fund Second Quarter 2014 Commentary.

Check out Westport Asset Management latest stock trades

Westport Fund Comments on Universal Health Services Inc - Jul 28, 2014

Health care holdings were the second largest industry sector contribution to the Fund’s performance at 128 basis points, similar to the 138 basis points contribution of the health care sector to the Russell Midcap® Index. The best performer among the portfolio holdings in health care was Universal Health Services, Inc., Class B shares (UHS) which contributed 64 basis points to performance with an 18% return in the first half.

From Westport Asset Management (Trades, Portfolio)’s Westport Fund Second Quarter 2014 Commentary.

Check out Westport Asset Management latest stock trades

Top Ranked Articles about Universal Health Services Inc

Baron Funds Comments on Universal Health Services Inc.
Universal Health Services, Inc. (NYSE:UHS) is a leading operator of acute care hospitals, and it is also the country’s largest provider of behavioral health services. The company’s shares rose sharply in late-June in response to the U.S. Supreme Court’s decision to uphold a key provision of the Affordable Care Act (ACA), which has expanded insurance coverage to almost 13 million Americans. The court’s decision removes meaningful future legal challenges to the ACA, which has driven a meaningful increase in hospital utilization. This court decision came on the heels of solid quarterly earnings results. As the dominant acute care provider in some of the fastest growing markets in the U.S., we continue to like Universal’s positioning and prospects. We are particularly excited about the opportunity for its behavioral health business to gain more favorable reimbursement treatment for Medicaid patients. Read more...
Westport Select Cap Fund Comments on Universal Health Services Inc
Universal Health Services, Inc., Class B shares (UHS), the fund’s largest position, was up nearly 6%, contributing 79 basis points. The company continues to benefit from the Affordable Care Actii (“Obamacare“) as it reported strong fourth quarter results and forecast continued above average growth for 2015. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 19.40
UHS's P/E(ttm) is ranked higher than
69% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 26.08 vs. UHS: 19.40 )
Ranked among companies with meaningful P/E(ttm) only.
UHS' s P/E(ttm) Range Over the Past 10 Years
Min: 8.06  Med: 14.02 Max: 25.79
Current: 19.4
8.06
25.79
Forward P/E 16.61
UHS's Forward P/E is ranked higher than
53% of the 75 Companies
in the Global Medical Care industry.

( Industry Median: 16.64 vs. UHS: 16.61 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 19.38
UHS's PE(NRI) is ranked higher than
70% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 25.40 vs. UHS: 19.38 )
Ranked among companies with meaningful PE(NRI) only.
UHS' s PE(NRI) Range Over the Past 10 Years
Min: 8.22  Med: 15.25 Max: 28.78
Current: 19.38
8.22
28.78
Price/Owner Earnings (ttm) 13.94
UHS's Price/Owner Earnings (ttm) is ranked higher than
80% of the 88 Companies
in the Global Medical Care industry.

( Industry Median: 26.92 vs. UHS: 13.94 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
UHS' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 7.61  Med: 13.96 Max: 186.83
Current: 13.94
7.61
186.83
P/B 3.06
UHS's P/B is ranked lower than
60% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 2.55 vs. UHS: 3.06 )
Ranked among companies with meaningful P/B only.
UHS' s P/B Range Over the Past 10 Years
Min: 1.01  Med: 2.12 Max: 3.54
Current: 3.06
1.01
3.54
P/S 1.45
UHS's P/S is ranked higher than
53% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 1.55 vs. UHS: 1.45 )
Ranked among companies with meaningful P/S only.
UHS' s P/S Range Over the Past 10 Years
Min: 0.33  Med: 0.76 Max: 1.68
Current: 1.45
0.33
1.68
PFCF 16.95
UHS's PFCF is ranked higher than
60% of the 112 Companies
in the Global Medical Care industry.

( Industry Median: 20.97 vs. UHS: 16.95 )
Ranked among companies with meaningful PFCF only.
UHS' s PFCF Range Over the Past 10 Years
Min: 8.37  Med: 15.13 Max: 325.73
Current: 16.95
8.37
325.73
POCF 11.12
UHS's POCF is ranked higher than
61% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 13.59 vs. UHS: 11.12 )
Ranked among companies with meaningful POCF only.
UHS' s POCF Range Over the Past 10 Years
Min: 3.21  Med: 8.22 Max: 23.76
Current: 11.12
3.21
23.76
EV-to-EBIT 13.78
UHS's EV-to-EBIT is ranked higher than
68% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 19.36 vs. UHS: 13.78 )
Ranked among companies with meaningful EV-to-EBIT only.
UHS' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.2  Med: 11.30 Max: 20
Current: 13.78
6.2
20
EV-to-EBITDA 10.25
UHS's EV-to-EBITDA is ranked higher than
71% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 13.84 vs. UHS: 10.25 )
Ranked among companies with meaningful EV-to-EBITDA only.
UHS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.3  Med: 7.80 Max: 12.3
Current: 10.25
4.3
12.3
PEG 1.51
UHS's PEG is ranked higher than
70% of the 82 Companies
in the Global Medical Care industry.

( Industry Median: 2.70 vs. UHS: 1.51 )
Ranked among companies with meaningful PEG only.
UHS' s PEG Range Over the Past 10 Years
Min: 0.41  Med: 1.05 Max: 4.2
Current: 1.51
0.41
4.2
Shiller P/E 33.53
UHS's Shiller P/E is ranked lower than
60% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 27.41 vs. UHS: 33.53 )
Ranked among companies with meaningful Shiller P/E only.
UHS' s Shiller P/E Range Over the Past 10 Years
Min: 10.2  Med: 21.41 Max: 40.68
Current: 33.53
10.2
40.68
Current Ratio 0.97
UHS's Current Ratio is ranked lower than
69% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.35 vs. UHS: 0.97 )
Ranked among companies with meaningful Current Ratio only.
UHS' s Current Ratio Range Over the Past 10 Years
Min: 0.97  Med: 1.56 Max: 1.98
Current: 0.97
0.97
1.98
Quick Ratio 0.90
UHS's Quick Ratio is ranked lower than
67% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 1.23 vs. UHS: 0.90 )
Ranked among companies with meaningful Quick Ratio only.
UHS' s Quick Ratio Range Over the Past 10 Years
Min: 0.9  Med: 1.43 Max: 1.78
Current: 0.9
0.9
1.78
Days Inventory 41.48
UHS's Days Inventory is ranked lower than
74% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 18.31 vs. UHS: 41.48 )
Ranked among companies with meaningful Days Inventory only.
UHS' s Days Inventory Range Over the Past 10 Years
Min: 8.27  Med: 9.39 Max: 42.77
Current: 41.48
8.27
42.77
Days Sales Outstanding 54.14
UHS's Days Sales Outstanding is ranked lower than
67% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 43.55 vs. UHS: 54.14 )
Ranked among companies with meaningful Days Sales Outstanding only.
UHS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.28  Med: 52.20 Max: 58.05
Current: 54.14
42.28
58.05
Days Payable 134.95
UHS's Days Payable is ranked higher than
79% of the 152 Companies
in the Global Medical Care industry.

( Industry Median: 37.56 vs. UHS: 134.95 )
Ranked among companies with meaningful Days Payable only.
UHS' s Days Payable Range Over the Past 10 Years
Min: 19.74  Med: 24.65 Max: 137.23
Current: 134.95
19.74
137.23

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.30
UHS's Dividend Yield is ranked lower than
95% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 1.76 vs. UHS: 0.30 )
Ranked among companies with meaningful Dividend Yield only.
UHS' s Dividend Yield Range Over the Past 10 Years
Min: 0.17  Med: 0.48 Max: 0.99
Current: 0.3
0.17
0.99
Dividend Payout 0.06
UHS's Dividend Payout is ranked higher than
98% of the 129 Companies
in the Global Medical Care industry.

( Industry Median: 0.38 vs. UHS: 0.06 )
Ranked among companies with meaningful Dividend Payout only.
UHS' s Dividend Payout Range Over the Past 10 Years
Min: 0.03  Med: 0.07 Max: 0.57
Current: 0.06
0.03
0.57
Dividend Growth (3y) 26.00
UHS's Dividend Growth (3y) is ranked higher than
79% of the 73 Companies
in the Global Medical Care industry.

( Industry Median: 11.50 vs. UHS: 26.00 )
Ranked among companies with meaningful Dividend Growth (3y) only.
UHS' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 58.7
Current: 26
0
58.7
Forward Dividend Yield 0.30
UHS's Forward Dividend Yield is ranked lower than
98% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 1.69 vs. UHS: 0.30 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 0.57
UHS's Yield on cost (5-Year) is ranked lower than
89% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 1.77 vs. UHS: 0.57 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
UHS' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.33  Med: 0.94 Max: 1.93
Current: 0.57
0.33
1.93
3-Year Average Share Buyback Ratio -0.20
UHS's 3-Year Average Share Buyback Ratio is ranked higher than
75% of the 119 Companies
in the Global Medical Care industry.

( Industry Median: -1.80 vs. UHS: -0.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
UHS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.2  Med: 1.80 Max: 3.6
Current: -0.2
-1.2
3.6

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 18.91
UHS's Price/Tangible Book is ranked lower than
96% of the 165 Companies
in the Global Medical Care industry.

( Industry Median: 3.56 vs. UHS: 18.91 )
Ranked among companies with meaningful Price/Tangible Book only.
UHS' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.18  Med: 4.55 Max: 317.57
Current: 18.91
2.18
317.57
Price/Projected FCF 1.10
UHS's Price/Projected FCF is ranked higher than
71% of the 91 Companies
in the Global Medical Care industry.

( Industry Median: 1.73 vs. UHS: 1.10 )
Ranked among companies with meaningful Price/Projected FCF only.
UHS' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.74  Med: 1.15 Max: 33.96
Current: 1.1
0.74
33.96
Price/DCF (Earnings Based) 0.73
UHS's Price/DCF (Earnings Based) is ranked higher than
93% of the 29 Companies
in the Global Medical Care industry.

( Industry Median: 1.73 vs. UHS: 0.73 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.92
UHS's Price/Median PS Value is ranked lower than
90% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. UHS: 1.92 )
Ranked among companies with meaningful Price/Median PS Value only.
UHS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.5  Med: 1.07 Max: 2.16
Current: 1.92
0.5
2.16
Price/Peter Lynch Fair Value 2.45
UHS's Price/Peter Lynch Fair Value is ranked lower than
54% of the 46 Companies
in the Global Medical Care industry.

( Industry Median: 2.20 vs. UHS: 2.45 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
UHS' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.43  Med: 1.27 Max: 3.75
Current: 2.45
0.43
3.75
Price/Graham Number 4.03
UHS's Price/Graham Number is ranked lower than
78% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 2.38 vs. UHS: 4.03 )
Ranked among companies with meaningful Price/Graham Number only.
UHS' s Price/Graham Number Range Over the Past 10 Years
Min: 0.96  Med: 1.87 Max: 12.49
Current: 4.03
0.96
12.49
Earnings Yield (Greenblatt) (%) 7.29
UHS's Earnings Yield (Greenblatt) (%) is ranked higher than
75% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. UHS: 7.29 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
UHS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 5  Med: 8.90 Max: 16.1
Current: 7.29
5
16.1
Forward Rate of Return (Yacktman) (%) 13.01
UHS's Forward Rate of Return (Yacktman) (%) is ranked higher than
59% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 10.71 vs. UHS: 13.01 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
UHS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9.8  Med: 18.60 Max: 28
Current: 13.01
9.8
28

More Statistics

Revenue (TTM) (Mil) $9,268
EPS (TTM) $ 6.95
Beta0.85
Short Percentage of Float1.96%
52-Week Range $100.82 - 148.57
Shares Outstanding (Mil)97.05

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 10,228 10,943 12,080
EPS ($) 7.38 8.10 8.73
EPS without NRI ($) 7.38 8.10 8.73
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
» More Articles for UHS

Headlines

Articles On GuruFocus.com
Quality Guru Stocks Include Amgen, Comcast Apr 21 2016 
Westport Trims Nearly 39% of Stakes in Portfolio Feb 12 2016 
Westport Select Cap Fund Third Quarter Commentary Oct 16 2015 
Westport Fund Third Quarter Commentary Oct 16 2015 
Olstein Funds 2015 Annual Letter to Shareholders Sep 24 2015 
Baron Funds Comments on Universal Health Services Inc. Aug 18 2015 
Westport Asset Management Sells Bulk of Two Stakes Aug 17 2015 
Mariko Gordon's Highest-Performing Stocks Jul 28 2015 
Westport Select Cap Fund Comments on Universal Health Services Inc May 29 2015 
Westport Funds Select Cap Fund Q3 Commentary Oct 25 2014 

More From Other Websites
Universal Health Services, Inc. Announces Dividend May 19 2016
UNIVERSAL HEALTH SERVICES INC Files SEC form 8-K, Submission of Matters to a Vote of Security... May 19 2016
Universal Health Services, Inc. Announces Dividend May 19 2016
Universal Health Services, Inc. Announces Offering Of Senior Secured Notes May 19 2016
Universal Health Services, Inc. Announces Offering Of Senior Secured Notes May 19 2016
Universal Health Services, Inc. To Present At The UBS Global Healthcare Conference May 17 2016
Universal Health Services, Inc. To Present At The UBS Global Healthcare Conference May 17 2016
[$$] Auction of Aurora Behavioral Health Care Draws Strategic Rather Than PE Interest May 13 2016
Moving Average Crossover Alert: Universal Health Services (UHS) May 13 2016
UNIVERSAL HEALTH SERVICES INC Financials May 12 2016
Universal Health Services, Inc. :UHS-US: Earnings Analysis: Q1, 2016 By the Numbers May 10 2016
UNIVERSAL HEALTH SERVICES INC Files SEC form 10-Q, Quarterly Report May 06 2016
Universal Health Services, Inc. To Present At The Bank of America Merrill Lynch 2016 Healthcare... May 05 2016
Universal Health Services, Inc. To Present At The Bank of America Merrill Lynch 2016 Healthcare... May 05 2016
UNIVERSAL HEALTH SERVICES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 03 2016
Universal Health Services, Inc. Announces Purchase Of Third-Party Minority Ownership Interests In... May 02 2016
Universal Health Services, Inc. Announces Purchase Of Third-Party Minority Ownership Interests In... May 02 2016
Universal Health (UHS) Tops Q1 Earnings on Strong Sales May 02 2016
Universal Health Realty reports 1Q results Apr 28 2016
Universal Health Realty reports 1Q results Apr 28 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)